Singapore, Singapore

Hui Yao

This inventor holds 2 USPTO granted patents. Top assignee: Nanyang Technological University. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hui Yao. Retrieved from https://idiyas.com/inventor/hui-yao-4hvnmu1t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Inventor Hui Yao

Introduction

Hui Yao is a prominent inventor based in Singapore, known for his contributions to the field of molecular biology and pharmacology. He has been instrumental in developing innovative solutions that enhance our understanding of nuclear receptor-related proteins.

Latest Patents

Hui Yao holds 2 patents, with his latest inventions focusing on co-crystals of the Nuclear receptor related 1 protein-ligand binding domain (Nurr1-LBD) in complex with a cyclopentenone prostaglandin. These patents provide methods for identifying or designing Nurr1-modulating ligands and compounds based on the described crystal structures. The applications of these ligands and compounds as Nurr1 modulators or medicaments are also highlighted in his work.

Career Highlights

Hui Yao is affiliated with Nanyang Technological University, where he continues to advance research in his field. His work has significantly contributed to the understanding of Nurr1 and its potential therapeutic applications.

Collaborations

Hui Yao collaborates with notable colleagues, including Ho Sup Yoon and Sreekanth Rajan, to further enhance the impact of his research.

Conclusion

Hui Yao's innovative work in the field of molecular biology exemplifies the importance of research in developing new therapeutic strategies. His contributions continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…